Updated version of QRISK2

Authors’ reply to Bird

BMJ 2012; 345 doi: http://dx.doi.org/10.1136/bmj.e5885 (Published 10 September 2012)
Cite this as: BMJ 2012;345:e5885

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Gary S Collins, senior medical statistician1,
  2. Douglas G Altman, director and professor1
  1. 1Centre for Statistics in Medicine, University of Oxford, Oxford OX2 6UD, UK
  1. gary.collins{at}csm.ox.ac.uk

Bird confirms that substantial data were missing for body mass index and the total serum cholesterol to high density lipoprotein cholesterol ratio.1 2 Most patients (1 221 873; 58.6%) had only one or no missing risk factors, and more than 400 000 had complete data.

Bird also queries our imputation strategy, which followed that of the original study developing QRISK2. The conclusions of the validation study are unlikely to be …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL